Purchase of Own Securities

UNITED DRUG PLC

('United Drug' or 'the Company')

Purchase of Own Securities

United Drug announces that on 3 October 2011, its broker Davy purchased 25,742 Ordinary Shares of nominal value €0.05 each in the capital of the Company ("Ordinary Shares") on behalf of the Company. The price paid for these Ordinary Shares was €2.2537 per share.

The 25,742 Ordinary Shares will be cancelled. Following the cancellation of these shares, the Company's issued share capital will reduce from 239,017,239 to 238,991,497. Each Ordinary Share carries one vote. United Drug also holds 7,528,066 Ordinary Shares in treasury, which do not carry voting rights. 

Ends 4 October 2011

Contact:

Karen Geoghegan

United Drug plc

Tel: +353-1-4637720